Company Filing History:
3 out of 717 
1 out of 80 
Years Active: 2016-2019
Title: James Bradley Breitmeyer: Innovator in Intravenous Acetaminophen
Introduction
James Bradley Breitmeyer is a notable inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of medicine, particularly in the development of intravenous acetaminophen formulations. With a total of 4 patents to his name, Breitmeyer has focused on improving pain management and fever treatment through innovative methods.
Latest Patents
Breitmeyer's latest patents include a groundbreaking formulation for reduced dose intravenous acetaminophen. This invention describes compositions and methods for administering acetaminophen intravenously at a single dose level of less than about 1000 mg. The aim is to effectively treat or prevent pain, such as postoperative pain, and/or fever. This innovation represents a significant advancement in the medical field, providing a safer and more effective option for patients.
Career Highlights
Throughout his career, James Bradley Breitmeyer has worked with reputable companies, including Mallinckrodt, Inc. and Mallinckrodt Hospital Products IP Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and contribute to important medical advancements.
Collaborations
Breitmeyer has collaborated with various professionals in the field, including his coworker Mike Allan Royal. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of medical treatments.
Conclusion
James Bradley Breitmeyer is a distinguished inventor whose work in intravenous acetaminophen has the potential to transform pain management and fever treatment. His contributions to the medical field are invaluable, and his innovative spirit continues to inspire advancements in healthcare.